AIP
VAXX

Ameritas Investment Partners’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

Ameritas Investment Partners’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-3,519
Closed -$2.52K – 3291
2024
Q1 		$2.52K Hold
3,519
– – ﹤0.01% 3018
2023
Q4 		$2.99K Hold
3,519
– – ﹤0.01% 3033
2023
Q3 		$4.82K Hold
3,519
– – ﹤0.01% 2994
2023
Q2 		$8.87K Buy
+3,519
New +$7.45K ﹤0.01% 2947

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $22.7B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

Ameritas Investment Partners's VAXX Position: Q2 2024 in Review

Ameritas Investment Partners sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 3,519 shares — an estimated $2.52K sold.

Ameritas Investment Partners first reported a position in VAXX in Q2 2023 and held it in 4 quarters. The position peaked at $8.87K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • Ameritas Investment Partners reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • Ameritas Investment Partners sold 3,519 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $2.52K.
  • Ameritas Investment Partners first reported a position in Vaxxinity, Inc. Class A Common Stock in Q2 2023 and held it in 4 quarters.
  • Ameritas Investment Partners's Vaxxinity, Inc. Class A Common Stock position peaked at $8.87K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on Ameritas Investment Partners's 13F filing for Q2 2024, filed 13 Aug 2024.